Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Net Margin (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Net Margin for 3 consecutive years, with 9.96% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 1159.0% to 9.96% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.64% through Dec 2025, up 792.0% year-over-year, with the annual reading at 11.29% for FY2025, 657.0% up from the prior year.
  • Net Margin for Q4 2025 was 9.96% at BioScience Health Innovations, down from 0.78% in the prior quarter.
  • The five-year high for Net Margin was 34.78% in Q1 2025, with the low at 218.68% in Q1 2023.
  • Average Net Margin over 3 years is 26.85%, with a median of 5.37% recorded in 2025.
  • The sharpest move saw Net Margin soared 19946bps in 2024, then plummeted -1159bps in 2025.
  • Over 3 years, Net Margin stood at 12.64% in 2023, then surged by 113bps to 1.63% in 2024, then tumbled by -710bps to 9.96% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 9.96%, 0.78%, and 26.04% for Q4 2025, Q3 2025, and Q2 2025 respectively.